Nuvation Bio Acquires Exclusive Rights to Safusitinib in Japan From Daiichi Sankyo
Nuvation Bio announced that it has completed the acquisition of exclusive rights to the IDH1‑mutant glioma drug safusitinib in Japan from partner Daiichi Sankyo. The agreement, finalized in April 2026, expands Nuvation’s portfolio and enables the company to advance the SIGMA trial in the Japanese market. The deal was disclosed during the company’s Q1 2026 earnings call.
Monument Health Acquires Rapid City (S.D.) Medical Center
Rapid City (S.D.) Medical Center officially joined Monument Health on May 1, completing a letter of intent signed in late January. The affiliation expands Monument Health’s five‑hospital system and allows RCMC patients to retain their providers while accessing broader resources....
Ensign Group Acquires 17 Texas Skilled Nursing Facilities
Ensign Group announced the acquisition of 15 stand-alone skilled nursing facilities and two continuing care retirement communities in Texas, adding over 2,000 nursing beds and 100 senior living units to its portfolio. The transaction, effective May 1, 2026, was executed...
Addus HomeCare Completes Acquisition of HomeCourt Home Care
Addus HomeCare Corp (NASDAQ: ADUS) closed its acquisition of Indiana‑based HomeCourt Home Care on May 1, 2026. The deal adds roughly $9.8 million in annual revenue, bringing combined Indiana revenue to just under $20 million, and supports Addus’s strategy to expand in the state...
Ligand Pharmaceuticals Invests $15M in Orchestra BioMed Under Royalty Financing Agreement
Orchestra BioMed Holdings announced receipt of a $15 million payment from Ligand Pharmaceuticals, completing the second tranche of their royalty‑based financing agreement. The funds support ongoing pivotal trials for the company's AVIM Therapy and Virtue SAB cardiovascular programs. The payment, part...
Medisolv Acquires Health Elements AI to Automate Data Abstraction and Expand Clinical Registry Support
Medisolv, a healthcare quality data management company, has acquired Health Elements AI, an AI-first software provider that automates clinical data abstraction. The deal aims to reduce manual chart review burden and broaden Medisolv's support for clinical registries. Financial terms were...
Medtronic Completes $585M Acquisition of CathWorks
Medtronic announced the completion of its acquisition of CathWorks, a developer of AI‑driven coronary artery disease diagnostic devices, for $585 million. The deal expands Medtronic’s interventional cardiology portfolio and adds the FFRangio system to its global offerings. The acquisition was reported...
PACS Group Acquires Ridgeway Senior Living Operations in Anchorage, Alaska
PACS Group, Inc. announced that its subsidiaries have acquired the operations of Ridgeway Senior Living in Anchorage, Alaska, marking its fourth facility in the state. The transaction includes adjacent land for a planned 150‑bed skilled nursing facility slated for completion...
Citrus Health Group Acquires The Medicine Group
Citrus Health Group, Inc., together with NaviMed Capital, announced the acquisition of The Medicine Group, a medical communications agency specializing in CNS disorders. The deal expands Citrus's expertise in CNS, oncology, and rare diseases, with founder Philip Sjostedt remaining as...
Illuminant Surgical Raises $8.4M Seed Round Led by Wing 2 Wing Ventures
Illuminant Surgical, a precision access and visualization company, announced a $8.4 million seed funding round to accelerate its Skylight™ platform. The round was led by Wing 2 Wing Ventures with participation from the National Science Foundation, National Cancer Institute, National Institute on Aging,...
Alesi Surgical Raises £7m ($8.8M) in Growth-Stage Funding Led by IW Capital
Alesi Surgical, a surgical technology firm, closed a £7m ($8.8M) funding round led by IW Capital with participation from IP Group and Mercia Ventures. The capital will fund international expansion and further development of its Ultravision2 platform to combat hazardous...
Eli Lilly Announces Acquisitions of Orna Therapeutics, Centessa Pharmaceuticals, Kelonia Therapeutics, and Ajax Therapeutics
Eli Lilly disclosed that it has signed agreements to acquire four biotech companies—Orna Therapeutics, Centessa Pharmaceuticals, Kelonia Therapeutics, and Ajax Therapeutics—as part of its Q1 2026 business development activity. The acquisitions aim to broaden Lilly's pipeline in obesity, diabetes, and...
Pinnaql Acquires Pharma Resource Group in Third Tuck-In Deal
Pinnaql, backed by Boomerang, has completed its third tuck‑in acquisition in ten months by buying Pharma Resource Group. The terms of the transaction were not disclosed.
Greatly Health Secures $4M Seed Funding to Scale MSK-Validated Integrative Oncology Platform
Greatly Health announced a $4 million seed round co‑led by Pear VC and Commonweal Ventures to expand its MSK‑validated virtual integrative oncology platform. The funding will support scaling of live group sessions, technology enhancements, and broader clinical team growth, aiming to...
Valneva SE Completes €84M Reserved Offering to Fund Vaccine Pipeline
French vaccine developer Valneva SE completed an €84 million reserved offering, adding a cash buffer for its Lyme disease and shigellosis vaccine candidates. The proceeds will support R&D, commercial operations, and strengthen the balance sheet as the company navigates a high‑risk...
OrthoPediatrics Corp Completes Acquisition of Brazilian Distributor Folomed
OrthoPediatrics Corp announced the acquisition of Folomed, a Brazilian distributor, to improve cash collection and ordering patterns in Latin America. The deal, disclosed during the company's Q1 2026 earnings call, aims to strengthen OrthoPediatrics' international footprint and accelerate growth in...
GSK Acquires RAPT Therapeutics for $2.2B
GlaxoSmithKline (GSK) completed the acquisition of RAPT Therapeutics, a company focused on food allergy treatments, in a $2.2 billion deal. The acquisition was highlighted in GSK's first‑quarter 2026 earnings update as part of its strategy to expand its specialty medicines pipeline.
Chiesi Group to Acquire KalVista Pharmaceuticals for $1.9B
Chiesi Group announced a $1.9 billion cash acquisition of KalVista Pharmaceuticals, paying $27 per share, a 40.3% premium. The deal adds KalVista's oral HAE drug Ekterly to Chiesi's rare-disease portfolio and is expected to close in the third quarter of...
CareDx to Acquire Naveris for $260M to Expand Into HPV-Driven Cancer MRD Monitoring
CareDx announced a definitive agreement to acquire precision oncology firm Naveris for up to $260 million, including $160 million cash up‑front and $100 million contingent on milestones. The deal will broaden CareDx’s portfolio into HPV‑driven cancer MRD monitoring and is slated to close...
Sabra Health Care REIT Completes $27M Acquisition of Managed Senior Housing Assets
Sabra Health Care REIT Inc announced it closed a $27 million acquisition of additional managed senior housing assets, adding to its portfolio after year‑end. The transaction expands Sabra’s senior housing footprint and supports its pipeline of $240 million in awarded deals slated...
Humana Agrees to Acquire Villages Health
Humana Inc. announced that it has agreed to acquire Villages Health, a provider of primary and specialty care services for Florida retirement communities. The acquisition is expected to close within the month, with terms undisclosed. This deal expands Humana's healthcare...
1520ai Acquires Hospice Analytics
Health‑care AI startup 1520ai announced the acquisition of data firm Hospice Analytics, expanding its hospice‑focused AI and analytics capabilities. The terms were undisclosed, and Hospice Analytics’ founder will continue to lead operations post‑merger.
AbbVie Secures Option to Acquire Kestrel Therapeutics for Up to $1.45B
AbbVie announced an exclusive right to acquire Kestrel Therapeutics, valued at up to $1.45 billion, contingent on Kestrel meeting development and regulatory milestones for its oral pan‑KRAS inhibitor KST‑6051. The agreement includes AbbVie funding the program and gives it the option...
Coultreon Biopharma Raises $125M Series A to Advance Novel Immunology Therapy
Belgian biotech Coultreon Biopharma announced a $125 million Series A round led by Sofinnova Investments, with participation from Novo Holdings, Forbion, Regeneron Ventures, Galapagos, Samsara BioCapital and Longwood Fund. The funding will be used to advance its lead SIK3 inhibitor COL‑5671 into...
Anthropic Acquires Coefficient Bio for $400M
Anthropic, the AI startup behind Claude, has completed the acquisition of Coefficient Bio, an AI‑driven drug discovery and clinical‑trials startup, for $400 million. The deal brings Coefficient Bio’s eight‑month‑old team, including former Genentech co‑founders, into Anthropic’s life‑sciences division. The acquisition marks...
Ligand Pharmaceuticals Acquires XOMA for $739 Million
Ligand Pharmaceuticals announced a $739 million acquisition of XOMA, aiming to expand its royalty revenue base and add late‑stage and commercial assets to its portfolio. The deal reflects ongoing consolidation in the biopharma sector among royalty‑financing, asset‑light companies. The transaction was...
Apollo Global Management Invests in Swiss Dental Firm vVardis, Valuing It at over $1B
Apollo Global Management Inc. has made an equity investment in vVardis Holding AG, a Swiss dental company founded by sisters Haley and Goly Abivardi. The deal values vVardis at more than $1 billion, while the founders retain about 70% ownership. The...
Johnson & Johnson to Acquire Atraverse Medical
Johnson & Johnson announced it will acquire Atraverse Medical, a developer of the FDA‑cleared Hotwire radio‑frequency guidewire for atrial fibrillation ablation. The deal value was not disclosed, and J&J expects to close the transaction in the second quarter of 2026....
Sun Pharma to Acquire Organon for $11.75B
Sun Pharmaceutical Industries announced an agreement to acquire all outstanding shares of US‑based Organon & Co for $14 per share in an all‑cash transaction valued at $11.75 billion. The deal, approved by both boards, will be effected via a merger with...
TriFetch Raises $1.9M Pre-Seed Round Led by Nexus Venture Partners
TriFetch, a healthcare AI startup, announced a $1.9 million pre-seed funding round led by Nexus Venture Partners, with participation from angels affiliated with Google, Hipprocratic, Mercor and MIT. The capital will be used to scale its automation platform for specialty...
The Hearing Clinic UK Acquires Congleton Hearing Centre
The Glasgow‑based Hearing Clinic UK announced it has acquired the award‑winning Congleton Hearing Centre in Cheshire. The target will retain its name and leadership under founder Anthony Berg, while The Hearing Clinic UK will invest in facility upgrades and digital...
Apollo Invests $1.25B in McKesson's Surgical Product Business
Apollo has completed a $1.25 billion minority investment in the surgical product business of McKesson Corporation, marking a significant private‑equity move into orthopedics and medical devices. The deal reflects growing interest in the sector driven by value‑based care trends and lower...
Avalyn Pharma Announces $182M IPO
Avalyn Pharma, a biotech developing inhaled versions of approved pulmonary fibrosis medicines, announced plans for an initial public offering targeting $182 million in proceeds. The IPO filing signals the company's move to public markets to fund its pipeline and expand...
IKS Health Acquires TruBridge in $565M All-Cash Deal
IKS Health announced a definitive agreement to acquire TruBridge in an all‑cash transaction at $26.25 per share, valuing the deal at up to $565 million. The acquisition, approved by both boards and funded by a term loan from Citibank and JPMorgan...
Amperos Health Raises $16M Series A Led by Bessemer Venture Partners
Amperos Health, an AI-native denial management platform, closed a $16M Series A round on April 22, 2026. The round was led by Bessemer Venture Partners with participation from Uncork Capital and Neo, and will fund expansion of its agentic AI...
Amneal Pharmaceuticals to Acquire Kashiv BioSciences for Up to $1.1B
Amneal Pharmaceuticals announced a definitive agreement to acquire Kashiv BioSciences for up to $1.1 billion, comprising $375 million in cash, $375 million in equity and up to $350 million in contingent payments. The deal aims to create a fully integrated global biosimilars platform and...
Intuitive Surgical Completes Acquisition of European Distributor Businesses
Intuitive Surgical announced that it has completed the acquisition of distributor businesses in Italy, Spain, and Portugal, expanding its European distribution network for its da Vinci and Ion platforms. The deal was disclosed in the company's Q1 2026 earnings call...
Eli Lilly Acquires Kelonia Therapeutics for $3.25B Upfront, up to $7B Total
Pharma giant Eli Lilly announced the acquisition of genetic‑medicine company Kelonia Therapeutics for an upfront payment of $3.25 billion, with potential milestone payments that could raise total consideration to $7 billion. Kelonia is developing an in‑vivo CAR‑T therapy for multiple myeloma. This...
Harris Health Alliance Acquires eRedbook to Boost Digital Child Health Across the NHS
Harris Health Alliance has completed the acquisition of eRedbook, the UK’s leading digital parent‑held child health record, from Heathersoft. The asset purchase adds the eRedbook platform, technology and customer base to HHA’s portfolio, strengthening its digital child health offerings for...
Purkinje Acquires LeoMed Technologies to Expand Virtual Care Platform
Montreal-based Purkinje announced it has acquired virtual care platform LeoMed Technologies, expanding its digital health solutions for hospital‑at‑home services across Canada. The acquisition integrates LeoMed’s platform with Purkinje’s workflow tools to improve care coordination and scale implementation in hospitals and...
QuikTrip Agrees to Sell MedWise Urgent‑care Network to Saint Francis Health System
QuikTrip is divesting its MedWise urgent‑care business, comprising nine clinics in Oklahoma, to Saint Francis Health System. The sale price was undisclosed, with proceeds earmarked for employee retention bonuses. The deal ends a six‑year experiment for the convenience retailer.
Spectrum.Life Acquires MindFit at Work, We Lysn, and Valion Health to Expand Into Australia
Ireland‑based digital mental health provider Spectrum.Life announced the acquisition of three Australian firms – MindFit at Work, We Lysn and Valion Health – to launch its platform in Australia. The deal unites mental health, rehabilitation and cancer care capabilities under...
CEPI Grants $51M to Moderna for H5N1 Bird Flu Vaccine Trial
The Coalition for Epidemic Preparedness Innovations (CEPI) announced a £40 million (≈$51 million) grant to fund a Phase 1 trial of Moderna’s mRNA vaccine against the H5N1 bird‑flu strain. In return, Moderna pledged to supply the vaccine quickly and affordably to low‑ and...
NHI Agrees to $560M Sale of 35-Property Nursing Home Portfolio to NHC
National Health Investors (NHI) announced an agreement to sell a portfolio of 35 nursing and independent living facilities to its current operator, National HealthCare Corporation (NHC), for $560 million. The transaction, expected to close on July 1, will reduce NHI’s skilled‑nursing...
UnitedHealth Group Acquires Alegeus Technologies
UnitedHealth Group announced it has acquired Alegeus Technologies, a privately held provider of consumer‑health services such as health savings accounts and flexible‑spending accounts. The financial terms of the transaction were not disclosed. The acquisition was disclosed as part of UnitedHealth's...
Tortugas Neuroscience Raises $106M in Seed and Series A Round to Advance CNS Drug Pipeline
Tortugas Neuroscience announced a $106 million financing round spanning its seed and Series A rounds, led by Cure Ventures with co‑lead investors The Column Group and AN Venture Partners. The capital will fund development of four in‑licensed CNS drugs, including candidates from...
Asahi Kasei Completes $920.7M Acquisition of German Biotech Aicuris
Japanese conglomerate Asahi Kasei has completed its acquisition of German biopharma Aicuris Anti‑infective Cures for approximately €780 million ($920.7 million). The deal adds three antiviral assets and royalties from Prevymis, and will be integrated via Asahi Kasei’s US subsidiary Veloxis Pharmaceuticals, boosting...
Midi Health Raises $100M in Series D Funding
US‑based women's telehealth platform Midi Health announced a $100 million Series D round, bringing its valuation to $1 billion. The funding will support scaling its AI‑driven health platform, expanding insurance coverage for 45 million women and further product development.
Injewelme Raises $1.2M in Funding Round Led by Temasek Trust's Catalytic Capital for Climate and Health
Singapore-based health‑tech startup injewelme announced it has closed a $1.2 million funding round, led by Temasek Trust’s Catalytic Capital for Climate and Health with participation from the Richardson Family. The capital will be used to advance its contactless health monitoring technology...
Cala Health Secures $50M Growth Capital From Trinity Capital
Cala Health, a California-based bioelectronic medicine company, announced it has secured $50 million in growth capital from alternative asset manager Trinity Capital. The funding will support commercial expansion and product innovation for its wearable neuromodulation therapy targeting tremor disorders. The round...